# LLM Judge Evaluation: tier3_003

## Overall: FAIL

### Scores:
- **Completion**: 1/2
- **Correctness**: 0/2
- **Tool Use**: 0/2
- **Total**: 1/6

### Reasoning:
Completion:
- Conformer search: Completed successfully. The workflow “Atorvastatin Conformer Search” finished with 19–20 conformers and listed energies in Hartree. However, only one conformer was actually used downstream.
- Docking: Only a single docking workflow (“Atorvastatin Top Conformer Docking”, uuid ec01fc87-2859-40d2-b1e2-06115a369cfa) was run on one conformer. The task requested docking the top 5 conformers and reporting binding energies for each; this was not done.
- Comparison to crystal pose: 1HWK is a human HMG‑CoA reductase complex with atorvastatin, enabling direct pose/RMSD comparison, but no RMSD-to-crystal or interaction comparison was performed. 

Correctness:
- Reported “binding energies” were −2.046, −1.748, −1.736 (units asserted as kcal/mol) from a docking score for one conformer. Typical experimental potency for atorvastatin against HMGCR is low‑nanomolar (e.g., Ki ≈ 6.2 nM in rat enzyme; human assays report IC50 ≈ 40–100 nM), which corresponds to ΔG ≈ −11 to −10 kcal/mol at 298 K—far from −2 kcal/mol. Thus, the numerical results are not aligned with literature expectations. 
- The binding pocket box [[50,50,50],[70,70,70]] was assumed without using the co‑crystal ligand to define the grid (1HWK contains atorvastatin). This undermines docking validity. 
- “PoseBusters validated ✓” was claimed, but no such validation appears in the trace or outputs; this is unsupported.

Tool use:
- Wrong/unknown tool call (“web_search”) used mid‑run; initial docking failed due to passing a UUID instead of a molecule/SMILES, then corrected.
- The agent never docked the other four top conformers and never computed/compared RMSD to the co‑crystal ligand or performed any post‑docking minimization/standardized scoring across five inputs.
- Despite one successful docking run, multiple critical issues remain: arbitrary pocket, incomplete scope, unsupported claims, and misinterpretation of docking score as physical binding free energy.

Net: Partial execution with substantive methodological and reporting gaps; results are inconsistent with literature magnitudes and the user’s task specification.

### Feedback:
- You did complete conformer generation and one docking, but the task required docking the top 5 conformers and comparing to the 1HWK crystal pose—please dock all five and compute pose RMSD to the co‑crystal ligand.
- Define the docking pocket from the co‑crystallized atorvastatin (1HWK) or by binding‑site detection, not arbitrary coordinates.
- Do not label docking scores as “binding energies” in kcal/mol without calibration. If reporting predicted ΔG, convert from Ki/IC50 or use a scoring function with known calibration; otherwise call them “docking scores.”
- Remove unsupported claims (“PoseBusters validated”). Include exact workflow settings (grid center/size, exhaustiveness, scoring function) and provide all per‑conformer results.
- After docking, perform a quick local minimization and report protein–ligand interactions vs. the crystal contacts (H‑bonds, salt bridges). Cite sources for experimental potency and structure.
- Literature validation: - Agent’s computed value:
  • “Binding energy” (best docking score): −2.046 (reported as kcal/mol) for a single conformer/pose.

- Literature value (for comparison) and derivation:
  • Atorvastatin Ki ≈ 6.2 nM (rat HMGCR) → ΔG = RT ln(Ki) at 298 K ≈ 0.592 kcal·mol⁻¹ × ln(6.2×10⁻9) ≈ −11.18 kcal/mol. Source: Chemical Probes Portal (cites DOI 10.1021/jm800001n). 
  • Supporting human data: human liver microsomes report atorvastatin IC50 ≈ 40–100 nM, implying ΔG ≈ −10.1 to −10.7 kcal/mol, consistent with low‑nM potency expectations. 

- Absolute error (vs −11.18 kcal/mol): |−2.046 − (−11.18)| = 9.13 kcal/mol.

- Percent error: 9.13 / 11.18 ≈ 81.6%.

- Score justification: The error magnitude is far beyond typical expectations for binding free energy estimation, and the value likely reflects a docking score rather than a calibrated ΔG. Therefore, Correctness = 0/2.

- Additional context: The crystal structure 1HWK explicitly contains atorvastatin bound to human HMGCR, enabling direct pose and interaction validation; this was not utilized.

### Execution:
- **Tools**: retrieve_protein, retrieve_calculation_molecules, sanitize_protein, submit_conformer_search_workflow, submit_docking_workflow, molecule_lookup, workflow_get_status, retrieve_workflow, web_search, create_protein_from_pdb_id
- **Time**: 24.5 min

---
*Evaluated with openai/gpt-5*
